Former 454 CEO Richard Begley has become vice president and general manager of PerkinElmer’s analytical sciences business, the company said last week.
Begley joins PerkinElmer from Ensemble Discovery, where he was president and chief executive officer. Prior to this, he was CEO and president of 454 Life Sciences.
Previously, Begley held senior management positions with Agilent/Hewlett-Packard, including director of manufacturing, general manager of the chemical solutions and mass spectrometry units, and head of worldwide R&D for the chemical analysis group. In addition, he has served with Schlumberger and Los Alamos National Laboratories.
Begley holds a PhD in applied physics, a master's degree in applied physics, and an executive MBA, all from Stanford University. He also holds a bachelor's degree in physics from Fordham University.
Paul Hawran will become chief financial officer of Sequenom, effective April 1, and has resigned from Sequenom’s board of directors, the company said last week.
Hawran brings to Sequenom more than 30 years of experience in finance, accounting, and tax, corporate, and strategic planning, and more than 21 years of experience in the pharmaceutical and biopharmaceutical industries. He served as chief financial officer of Neurocrine Biosciences from 1993 to 2006.
Prior to Neurocrine, he was vice president and treasurer at SmithKline Beecham, and he also served as director of finance at Warner Communications.
Hawran holds a BS in finance from St. John's University and an MS in taxation from Seton Hall University.
Former Applied Biosystems President Cathy Burzik has joined the board of directors of Bausch & Lomb, the company said last week.
Since October 2006, Burzik has been CEO of Kinetic Concepts, a San Antonio, Texas-based medical technology company.
Before joining KCI, she was president of ABI. Prior to that, she was CEO and president of Kodak Health Imaging Systems and general manager/vice president of corporate marketing. She also served on the board of directors at Cordis prior to its acquisition by Johnson&Johnson. At J&J, she ran the Critikon medical technology business and subsequently was appointed president of J&J's Ortho-Clinical Diagnostics unit.
Burzik holds a BA in mathematics from Canisius College in Buffalo, New York, and a MA in mathematics from the University of Buffalo.